Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 7, 1999, Pages 2373-2380

  Ter Maaten, Jan C ^a,b   De Boer, Hans ^a   Kamp, Otto ^a   Stuurman, Lotte ^a   Van Der Veen, Eduard A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; LIOTHYRONINE; SOMATOMEDIN C; THYROXINE;

ADULT; ANTHROPOMETRY; ARTICLE; BICYCLE ERGOMETRY; BODY COMPOSITION; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GROWTH HORMONE DEFICIENCY; HEART FUNCTION; HORMONAL THERAPY; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; LEG MUSCLE; MALE; MUSCULOSKELETAL DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033306143     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.7.2373     Document Type: Article

References (36)

1. Clinical aspects of growth hormone deficiency in adults
2. Premature mortality due to cardiovascular disease in hypopituitarism
3. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review
4. Growth hormone and the heart
5. Epidemiology of acromegaly in the Newcastle region
6. The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis
7. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers
8. Changes in subcutaneous and visceral fat during growth hormone replacement therapy in adult men
9. Anthropometric standardization reference manual
10. Quantification of body fat distribution in the abdomen using computed tomography
11. X-Ray dual absorptiometry: A new method for measurement of bone density
12. The consequences of childhood-onset growth hormone deficiency for adult bone mass
13. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
14. Cardiac exercise testing. Indications, staff, equipment, conduct, and procedures
15. Cardiovascular and renal effects of growth hormone
16. Cardiac performance and mass in adults with hypopituitarism: Effects of one year of growth hormone treatment
17. Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults. Preliminary data in a small group of patients
18. Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults
19. Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood
20. Cardiovascular effects of prolonged growth hormone replacement in adults
21. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation
22. Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength
23. Growth hormone treatment of adults with growth hormone deficiency: Results of a 13-month placebo controlled cross-over study
24. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH
25. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males
26. The effect of growth hormone on histomorphometric indices of bone structure and bone turnover in growth hormone deficient men
27. Growth hormone and the maintenance of adult bone density
28. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency
29. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women
30. The individualized responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age and gender
31. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment
32. Two years of replacement therapy in adults with growth hormone deficiency
33. Guidelines for optimizing growth hormone replacement therapy in adults
34. A low starting dose of genotropin in growth hormone-deficient adults
35. Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults